News & Perspective

Mar 04, 2004

Mar 04, 2004

New board to advise on 'dual use' research, announces HHS

(CIDRAP News) – A new government-wide effort to sustain the cutting-edge life sciences research for which the United States is known but to also guard against misuse of the knowledge and technologies growing from this research was announced today by Health and Human Services (HHS) Secretary Tommy Thompson.

Nov 17, 2011

Nov 17, 2011

H5N1 transmission experiment stirs concern

(CIDRAP News) – A national biosecurity board that monitors "dual use" research is apparently worried about an as-yet-published study in which a mutant form of H5N1 avian influenza virus was found to be easily transmissible in ferrets, which are considered good models for flu in humans.

Dec 20, 2011

Dec 20, 2011

US government urges journals to omit details of two H5N1 studies

(CIDRAP News) – In an unprecedented move, the US government, following an advisory panel's advice, has asked the journals Science and Nature to omit key details of two studies on the transmissibility of dangerous mutant strains of H5N1 influenza viruses in ferrets on grounds that the information could be misused by bioterrorists.

Jan 17, 2012

Jan 17, 2012

WHO to lead talks on controversial H5N1 studies

(CIDRAP News) – A World Health Organization (WHO) official said the agency will play a role in leading discussions on issues related to controversial H5N1 avian influenza transmission studies, as more experts called for a further global discussion of the issues.

Jan 25, 2012

Jan 25, 2012

Virus in one controversial H5N1 study wasn't lethal

(CIDRAP News) – Breaking a prolonged silence, the author of one of two controversial studies dealing with mutant H5N1 viruses said today that the virus his team created went airborne to spread among ferrets, but it didn't kill them.

Jan 30, 2012

Jan 30, 2012

Battle over H5N1 research continues in media, journals

(CIDRAP News) – The battle over dissemination of controversial research on mutant H5N1 avian influenza viruses continued in a flurry of commentaries and media letters in recent days, covering the full range of issues from the potential public health benefits to scientific censorship and the risk of bioterrorist exploitation of the findings.

Jan 31, 2012

Jan 31, 2012

Experts continue to clash over NSABB recommendation

(CIDRAP News) – As more details emerged today on an advisory group's recommendation for scientific journals to withhold key details of H5N1 transmission studies, another round of discussion on both sides of the controversy played out today on the pages of a major microbiology journal.

Feb 03, 2012

Feb 03, 2012

Live debate airs major divisions in H5N1 research battle

(CIDRAP News) – The controversy over research about potentially dangerous H5N1 viruses heated up last night in a New York City debate that featured some of the leading voices exchanging blunt comments on the alleged risks and benefits of publishing or withholding the full details of the studies.

Feb 08, 2012

Feb 08, 2012

Experts: Dual-use H5N1 studies may not hasten pandemic response

(CIDRAP News) – International experts say that, while experiments on H5N1 avian flu transmission in mammals are important, publishing full details of such "dual-use" studies likely will not speed up the vaccine response in a pandemic, according to a news report and editorial in Nature today.

Feb 17, 2012

Feb 17, 2012

WHO H5N1 study group extends moratorium, calls for full publication

(CIDRAP News) – Flu and public health experts meeting at the World Health Organization (WHO) on issues surrounding two controversial H5N1 transmission studies today agreed on a plan to extend a voluntary research moratorium but publish the full results at a later date.

The temporary moratorium applies to new lab-modified H5N1 viruses, though the group agreed the research on naturally occurring H5N1 viruses must continue to protect public health.

Pages

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»